The clinical status of irinotecan (CPT-11), a novel water soluble camptothecin analogue: 1996.
O'Reilly
S
S
Division of Medical Oncology, Johns Hopkins Oncology Center, Baltimore, Maryland 21287-8934, USA.
Rowinsky
E K
EK
D000972:Antineoplastic Agents, Phytogenic / Q000378:metabolism / Q000627:therapeutic use; D002166:Camptothecin / Q000031:analogs & derivatives* / Q000378:metabolism / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006801:Humans; D000077146:Irinotecan; D009369:Neoplasms / Q000188:drug therapy*
D000972:Antineoplastic Agents, Phytogenic; D000077146:Irinotecan; D002166:Camptothecin